STARTUP PROFILE

Neurode

COUNTRY
Australia
FOUNDED
2021
CATEGORY
Neuromodulation
Offerign a wearable, drug-free headband that stimulates and tracks brain activity for managing ADHD symptoms in just 20 minutes daily.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

Neurode

news and updates

Sep 2024: Neurode raised a US$3.5M (A$5.2M) pre-seed led by Khosla Ventures with PsyMed Ventures. The funding supports clinical trials of the Neurode Wave, an at-home ADHD headband that combines prefrontal electrical stimulation with light-based brain sensing. It is not yet cleared by the FDA or Australia’s TGA.

•
Neurofounders Insights
$   Funding   -
Pre-seed
MODALITY
tDCS/tES
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Patients
REGULATORY STAGE
Investigational
Neurode is positioned as a consumer-friendly ADHD neuromodulation platform, combining stimulation and tracking in a short daily routine. It straddles wellness and therapy, with the main strategic question being whether it can achieve medical-grade outcomes with consumer-grade simplicity.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Neurode
No items found.